137 related articles for article (PubMed ID: 16204436)
1. Posttraumatic stress associated with cancer history and BRCA1/2 genetic testing.
Hamann HA; Somers TJ; Smith AW; Inslicht SS; Baum A
Psychosom Med; 2005; 67(5):766-72. PubMed ID: 16204436
[TBL] [Abstract][Full Text] [Related]
2. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
[TBL] [Abstract][Full Text] [Related]
3. Tolerance for uncertainty and perceived risk among women receiving uninformative BRCA1/2 test results.
O'Neill SC; DeMarco T; Peshkin BN; Rogers S; Rispoli J; Brown K; Valdimarsdottir H; Schwartz MD
Am J Med Genet C Semin Med Genet; 2006 Nov; 142C(4):251-9. PubMed ID: 17024668
[TBL] [Abstract][Full Text] [Related]
4. Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks? Rotterdam/Leiden Genetics Working Group.
Lodder LN; Frets PG; Trijsburg RW; Meijers-Heijboer EJ; Klijn JG; Duivenvoorden HJ; Tibben A; Wagner A; van der Meer CA; Devilee P; Cornelisse CJ; Niermeijer MF
J Med Genet; 1999 Dec; 36(12):906-13. PubMed ID: 10593998
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer.
van Dijk S; Timmermans DR; Meijers-Heijboer H; Tibben A; van Asperen CJ; Otten W
J Clin Oncol; 2006 Aug; 24(22):3672-7. PubMed ID: 16877736
[TBL] [Abstract][Full Text] [Related]
6. No evidence of false reassurance among women with an inconclusive BRCA1/2 genetic test result.
Dorval M; Gauthier G; Maunsell E; Dugas MJ; Rouleau I; Chiquette J; Plante M; Laframboise R; Gaudet M; Bridge PJ; Simard J
Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2862-7. PubMed ID: 16365001
[TBL] [Abstract][Full Text] [Related]
7. Fertility intentions following testing for a BRCA1 gene mutation.
Smith KR; Ellington L; Chan AY; Croyle RT; Botkin JR
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):733-40. PubMed ID: 15159303
[TBL] [Abstract][Full Text] [Related]
8. Accommodating risk: responses to BRCA1/2 genetic testing of women who have had cancer.
Hallowell N; Foster C; Eeles R; Ardern-Jones A; Watson M
Soc Sci Med; 2004 Aug; 59(3):553-65. PubMed ID: 15144764
[TBL] [Abstract][Full Text] [Related]
9. Coping with genetic testing for breast cancer susceptibility.
Dougall AL; Smith AW; Somers TJ; Posluszny DM; Rubinstein WS; Baum A
Psychosom Med; 2009 Jan; 71(1):98-105. PubMed ID: 19124622
[TBL] [Abstract][Full Text] [Related]
10. Psychological distress and quality of life associated with genetic testing for breast cancer risk.
Smith AW; Dougall AL; Posluszny DM; Somers TJ; Rubinstein WS; Baum A
Psychooncology; 2008 Aug; 17(8):767-73. PubMed ID: 17992698
[TBL] [Abstract][Full Text] [Related]
11. Morphology of breast cancer as a means of triage of patients for BRCA1 genetic testing.
Farshid G; Balleine RL; Cummings M; Waring P;
Am J Surg Pathol; 2006 Nov; 30(11):1357-66. PubMed ID: 17063074
[TBL] [Abstract][Full Text] [Related]
12. Novel germline BRCA1 and BRCA2 mutations in Turkish women with breast and/or ovarian cancer and their relatives.
Egeli U; Cecener G; Tunca B; Tasdelen I
Cancer Invest; 2006; 24(5):484-91. PubMed ID: 16939956
[TBL] [Abstract][Full Text] [Related]
13. Family history as a predictor of uptake of cancer preventive procedures by women with a BRCA1 or BRCA2 mutation.
Metcalfe KA; Foulkes WD; Kim-Sing C; Ainsworth P; Rosen B; Armel S; Poll A; Eisen A; Gilchrist D; Chudley A; Ghadirian P; Maugard C; Lemire EG; Sun P; Narod SA
Clin Genet; 2008 May; 73(5):474-9. PubMed ID: 18341607
[TBL] [Abstract][Full Text] [Related]
14. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.
van Oostrom I; Meijers-Heijboer H; Duivenvoorden HJ; Bröcker-Vriends AH; van Asperen CJ; Sijmons RH; Seynaeve C; Van Gool AR; Klijn JG; Tibben A
Patient Educ Couns; 2007 Jan; 65(1):58-68. PubMed ID: 16872788
[TBL] [Abstract][Full Text] [Related]
15. High risk of contralateral breast carcinoma in women with hereditary/familial non-BRCA1/BRCA2 breast carcinoma.
Shahedi K; Emanuelsson M; Wiklund F; Gronberg H
Cancer; 2006 Mar; 106(6):1237-42. PubMed ID: 16475207
[TBL] [Abstract][Full Text] [Related]
16. Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study.
van Oostrom I; Meijers-Heijboer H; Lodder LN; Duivenvoorden HJ; van Gool AR; Seynaeve C; van der Meer CA; Klijn JG; van Geel BN; Burger CW; Wladimiroff JW; Tibben A
J Clin Oncol; 2003 Oct; 21(20):3867-74. PubMed ID: 14551306
[TBL] [Abstract][Full Text] [Related]
17. Using the common sense model to understand perceived cancer risk in individuals testing for BRCA1/2 mutations.
Kelly K; Leventhal H; Andrykowski M; Toppmeyer D; Much J; Dermody J; Marvin M; Baran J; Schwalb M
Psychooncology; 2005 Jan; 14(1):34-48. PubMed ID: 15386791
[TBL] [Abstract][Full Text] [Related]
18. Posttraumatic stress disorder and physical comorbidity among female children and adolescents: results from service-use data.
Seng JS; Graham-Bermann SA; Clark MK; McCarthy AM; Ronis DL
Pediatrics; 2005 Dec; 116(6):e767-76. PubMed ID: 16322133
[TBL] [Abstract][Full Text] [Related]
19. Uptake of testing for BRCA1/2 mutations in South East Scotland.
Holloway SM; Bernhard B; Campbell H; Lam WW
Eur J Hum Genet; 2008 Aug; 16(8):906-12. PubMed ID: 18285832
[TBL] [Abstract][Full Text] [Related]
20. Spiritual faith and genetic testing decisions among high-risk breast cancer probands.
Schwartz MD; Hughes C; Roth J; Main D; Peshkin BN; Isaacs C; Kavanagh C; Lerman C
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):381-5. PubMed ID: 10794482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
